샘플 요청 목록

 카트 문의
시장보고서
상품코드
1564953

세계의 혈액 응고/지혈 분석기 시장

Coagulation / Hemostasis Analyzers
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 194 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈액 응고/지혈 분석기 세계 시장, 2030년까지 50억 달러에 달할 것으로 전망

2023년 41억 달러로 추정되는 혈액 응고/지혈 분석기 세계 시장은 2023-2030년간 연평균 3.0%의 성장률을 기록하며 2030년에는 50억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 임상 검사 분석기 부문은 CAGR 2.2%를 기록하여 분석 기간 종료 시점에 38억 달러에 도달할 것으로 예상됩니다. 현장 검사 분석기 부문은 분석 기간 동안 CAGR 6.1%의 성장률을 나타낼 것으로 예상됩니다.

미국 시장은 11억 달러, 중국 CAGR 5.3%로 성장 전망

미국 혈액 응고/지혈 분석기 시장은 2023년 11억 달러 규모로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년의 분석 기간 동안 5.3%의 연평균 복합 성장률(CAGR)로 2030년까지 10억 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 0.5%와 3.7%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 1.2%의 성장률을 보일 것으로 예상됩니다.

세계 혈액 응고/지혈 분석기 시장 - 주요 동향 및 촉진요인 요약

혈액 응고/지혈 분석기가 헬스케어에 필수적인 이유는 무엇인가?

응고 및 지혈 분석기는 현대 의료에서 필수적인 도구입니다. 이 분석기는 체내 혈액 응고 기능을 평가하는 데 사용되며, 혈액 응고 관련 질환의 진단, 치료 및 관리에 필수적입니다. 혈액 응고 장애는 과도한 출혈과 혈전증(과도한 응고)을 유발할 수 있으며, 이 두 가지 모두 생명을 위협할 수 있습니다. 응고 분석기는 프로트롬빈 시간(PT), 활성화 부분 트롬보플라스틴 시간(aPTT), 피브리노겐 수치, D-다이머 등 다양한 검사를 실시하여 의료진이 환자의 혈액 응고 정도를 판단하는 데 도움을 줍니다. 이러한 검사는 항응고제 치료를 받는 환자 관리, 혈우병과 같은 출혈성 질환 평가, 수술 준비 등에 필수적입니다. 외상이나 뇌졸중과 같은 응급 상황에서는 신속한 응고 검사를 통해 즉각적인 치료 방침을 결정하고 생명을 구할 수 있습니다. 혈액 응고의 중요성을 고려할 때, 응고 분석기는 심장병학, 종양학, 외과 분야뿐만 아니라 일반 임상 진단에서도 핵심적인 역할을 담당하고 있습니다.

응고 및 지혈 분석기는 왜 첨단 장비인가?

응고 및 지혈 분석기는 신속하고 정확하며 신뢰할 수 있는 결과를 얻기 위해 최첨단 기술이 집약된 첨단 장비입니다. 이 장비들은 광학, 기계적, 전기 화학적 방법 등 다양한 방법으로 응고 과정을 측정합니다. 예를 들어, 광학 분석기는 혈액이 응고되기 시작할 때 시료의 탁도(탁도) 변화를 감지하여 정확한 실시간 데이터를 제공합니다. 기계 시스템은 혈액 샘플의 움직임과 점도 변화를 모니터링하고 전기화학 시스템은 혈전 형성에 따른 전기 전도도 변화를 측정합니다. 이러한 기술이 통합되어 있기 때문에 응고 검사가 신속하게 완료됩니다. 이는 신속한 진단이 최우선 순위인 중환자 치료에서 필수적입니다. 최신 응고 분석기는 자동화 기능도 갖추고 있어 여러 검체를 동시에 처리할 수 있어 검사실 효율성이 향상됩니다. 또한 소량의 혈액으로 다양한 검사를 수행할 수 있어 현장 진료뿐만 아니라 고처리량 임상 실험실에서 사용하기에 이상적입니다. 이 분석기에는 고급 알고리즘과 데이터 분석 도구가 탑재되어 있어 인위적인 오류를 제거하고 표준화된 결과를 제공하여 정확도를 높입니다. 또한, 검사 정보 시스템(LIS)과 연동되는 경우가 많아 의료진 전체가 원활하게 데이터를 공유할 수 있습니다. 이러한 기술 통합을 통해 응고 분석기는 더욱 빠르고 신뢰할 수 있을 뿐만 아니라 확장성이 향상되어 병원, 클리닉, 연구소 등 수요 증가에 대응할 수 있게 되었습니다.

응고 및 지혈 분석기는 현대 의학에서 어떻게 진화하고 있는가?

응고 및 지혈 분석기는 개인 맞춤형 의료, 외래 진료, 기술 발전 등 새로운 수요에 따라 변화하는 의료 환경에 맞추어 빠르게 진화하고 있습니다. 가장 큰 트렌드 중 하나는 응고 분석기의 소형화 및 휴대성 향상으로 POCT(Point of Care Testing)가 가능해졌습니다는 점입니다. 이러한 변화로 인해 의료 서비스 제공업체는 환자의 침대 옆이나 응급실, 심지어 재택치료 현장에서 응고 검사 결과를 실시간으로 직접 제공할 수 있게 되었습니다. 휴대용 응고 분석기는 와파린이나 직접 경구용 항응고제(DOAC) 등 과다 출혈이나 혈전 형성 등의 합병증을 피하기 위해 빈번한 모니터링이 필요한 항응고 요법을 장기간 복용하는 환자에게 특히 유용합니다. 현장 검사 및 치료 조정이 가능해짐에 따라 환자의 예후가 개선되고, 현대 의료에서 중요한 고려 사항인 병원 방문의 필요성을 줄일 수 있습니다. 또한, 디지털 기술과 인공지능(AI)의 통합으로 응고 분석기의 기능이 향상되고 있습니다. AI와 머신러닝 알고리즘은 응고 검사 결과를 분석하는 데 점점 더 많이 사용되고 있으며, 환자의 건강 상태에 대한 더 깊은 통찰력을 제공하고 응고 장애를 더 정확하게 예측할 수 있도록 돕고 있습니다. 이러한 시스템은 비정상적인 결과를 표시하거나 과거 데이터를 기반으로 잠재적인 진단 및 치료법 조정을 제안하여 임상의가 보다 현명한 판단을 내릴 수 있도록 돕습니다. 또한, 많은 최신 분석 장비는 클라우드 연결 기능을 갖추고 있어 의료 제공업체와 검사실 간의 원격 모니터링 및 실시간 데이터 공유를 가능하게 합니다. 이는 응고 모니터링이 필수적인 만성 환자나 화학 요법과 같은 복잡한 치료를 받고 있는 환자 관리에 특히 유용합니다. 시약 처방, 센서 기술 및 자동화의 발전으로 이러한 분석 장비는 더욱 정확하고 효율적이 되어 시료 오염 및 부정확한 측정값의 가능성을 줄이고 있습니다.

혈액 응고/지혈 분석기 시장의 성장을 주도하는 요인은 무엇인가?

응고 및 지혈 분석기 시장의 성장은 의료 기술의 발전, 환자의 요구, 의료 모델의 진화와 직접적으로 관련된 몇 가지 요인에 의해 주도되고 있습니다. 주요 요인 중 하나는 심혈관 질환, 혈전 색전증 및 지속적인 혈액 응고 모니터링이 필요한 만성 질환의 이환율 증가입니다. 심부정맥혈전증(DVT), 심방세동, 폐색전증과 같은 질환이 유행하면서 신뢰할 수 있고 효율적인 응고 분석기에 대한 수요가 급증하고 있습니다. 이러한 질환은 환자에게 항응고 요법을 시행해야 하는 경우가 많으며, 치료 효과를 확인하고 부작용을 예방하기 위해 빈번한 모니터링이 필요하기 때문에 실험실 기반 응고 검사와 현장 응고 검사 모두에 대한 수요가 증가하고 있습니다. 개인 맞춤형 의료 증가도 시장 성장에 기여하고 있습니다. 특히 종양학 및 심혈관 치료에서 개인 맞춤형 치료 계획이 증가함에 따라 혈액 응고를 정확하고 빈번하게 모니터링해야 할 필요성이 대두되고 있습니다. 유전자 치료나 표적 생물학적 제제 등 맞춤 치료는 혈액 응고와 관련된 고유한 위험을 수반하는 경우가 많기 때문에 면밀하고 지속적인 관찰이 필요합니다. 또한, 전 세계적으로 고령화가 진행되고 있는 것도 큰 요인입니다. 고령자는 혈액 응고 장애에 취약하며, 뇌졸중, 당뇨병, 심장병 등의 질환을 관리하기 위해 정기적인 응고 검사가 필요할 가능성이 높습니다. 이러한 인구 통계학적 변화는 고급 지혈 분석 장비에 대한 안정적인 수요를 견인하고 있습니다. 또 다른 시장 성장의 또 다른 촉진요인은 신흥 시장의 의료 인프라가 확대되고 있으며, 정부와 의료 서비스 제공업체가 증가하는 환자 수요를 충족시키기 위해 최신 진단 도구에 투자하고 있다는 점입니다. 마지막으로 자동화, AI, 실시간 데이터 공유의 통합과 같은 기술 혁신은 응고 분석기를 보다 효율적이고 정확하며 사용하기 쉽게 만들고 있습니다. 이러한 발전은 검사실과 의료 서비스 제공업체가 신속하고 정확한 응고 검사에 대한 수요 증가에 대응하는 데 도움이 되고 있으며, 이는 시장의 추가 성장을 가속하고 있습니다. 이러한 요인들이 결합되어 현대 의료에서 응고 분석기의 중요성이 확대되고 있으며, 혈액 응고 장애의 진단과 관리에 있어 응고 분석기의 관련성이 지속될 것으로 보입니다.

조사 대상 기업 예시(총 41개)

  • Alere, Inc.
  • Diagnostica Stago SAS
  • Helena Laboratories, Inc.
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Roche Diagnostics（Schweiz）AG
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.10.08

Global Coagulation / Hemostasis Analyzers Market to Reach US$5.0 Billion by 2030

The global market for Coagulation / Hemostasis Analyzers estimated at US$4.1 Billion in the year 2023, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2023-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$3.8 Billion by the end of the analysis period. Growth in the Point-of-Care Testing Analyzers segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 5.3% CAGR

The Coagulation / Hemostasis Analyzers market in the U.S. is estimated at US$1.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.5% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Coagulation / Hemostasis Analyzers Market - Key Trends and Drivers Summarized

Why Are Coagulation/Hemostasis Analyzers So Crucial in Healthcare?

Coagulation, or hemostasis, analyzers are vital tools in modern healthcare. These analyzers are used to assess the body’s blood clotting function, which is critical for diagnosing, treating, and managing conditions related to blood coagulation. Blood clotting disorders can lead to either excessive bleeding or thrombosis (excessive clotting), both of which are dangerous and potentially life-threatening. Coagulation analyzers perform a range of tests, including prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen levels, and D-dimer, to help healthcare providers determine how well a patient’s blood clots. These tests are essential for managing patients on anticoagulant therapies, evaluating bleeding disorders like hemophilia, and preparing patients for surgery. In emergency situations, such as trauma or stroke, rapid coagulation testing can guide immediate treatment decisions, saving lives. Given the critical nature of blood clotting in overall health, coagulation analyzers are central to diagnostics in cardiology, oncology, and surgical fields, as well as general clinical practice.

What Makes Coagulation/Hemostasis Analyzers So Advanced?

Coagulation and hemostasis analyzers are sophisticated instruments that rely on cutting-edge technologies to deliver fast, accurate, and reliable results. These devices use a variety of methods to measure the clotting process, including optical, mechanical, and electrochemical techniques. For instance, optical analyzers detect changes in the turbidity (cloudiness) of a sample as the blood begins to clot, providing precise and real-time data. Mechanical systems monitor the movement or viscosity changes in blood samples, while electrochemical systems measure changes in electrical conductivity as a clot forms. The integration of these technologies ensures that coagulation tests can be completed quickly, a necessity in critical care situations where rapid diagnosis is paramount. Modern coagulation analyzers also feature automation capabilities, allowing them to process multiple samples simultaneously, thereby increasing laboratory efficiency. They can perform a range of tests on small volumes of blood, making them ideal for use in high-throughput clinical laboratories, as well as in point-of-care settings. These analyzers are equipped with sophisticated algorithms and data analysis tools, which enhance accuracy by eliminating human error and providing standardized results. Additionally, they are often linked to laboratory information systems (LIS), enabling seamless data sharing across healthcare teams. This integration of technology makes coagulation analyzers not only faster and more reliable but also more scalable, ensuring that they can meet the growing demands of hospitals, clinics, and research institutions alike.

How Are Coagulation/Hemostasis Analyzers Evolving in Modern Medicine?

Coagulation and hemostasis analyzers are evolving rapidly in response to the changing landscape of healthcare, driven by new demands in personalized medicine, outpatient care, and technological advancements. One of the major trends is the miniaturization and portability of coagulation analyzers, which enables point-of-care testing (POCT). This shift allows healthcare providers to deliver real-time coagulation results directly at the patient’s bedside, in emergency rooms, or even in home healthcare settings. Portable coagulation analyzers are particularly beneficial for patients on long-term anticoagulant therapies, such as warfarin or direct oral anticoagulants (DOACs), who require frequent monitoring to avoid complications like excessive bleeding or clot formation. The ability to test and adjust treatment on-site improves patient outcomes and reduces the need for hospital visits, a critical consideration in modern healthcare. Moreover, the integration of digital technologies and artificial intelligence (AI) is enhancing the capabilities of coagulation analyzers. AI and machine learning algorithms are increasingly being used to analyze coagulation test results, providing deeper insights into patient health and enabling more accurate predictions of clotting disorders. These systems can flag abnormal results and even suggest potential diagnoses or treatment adjustments based on historical data, helping clinicians make more informed decisions. Additionally, many modern analyzers are now equipped with cloud connectivity, allowing for remote monitoring and real-time data sharing between healthcare providers and laboratories. This is particularly useful for managing chronic patients and those undergoing complex treatments like chemotherapy, where coagulation monitoring is essential. Advances in reagent formulations, sensor technology, and automation are also making these analyzers more precise and efficient, reducing the likelihood of sample contamination or inaccurate readings.

What Is Driving the Growth of the Coagulation/Hemostasis Analyzers Market?

The growth in the coagulation/hemostasis analyzers market is driven by several factors directly related to advancements in medical technology, patient needs, and evolving healthcare models. One of the primary drivers is the rising incidence of cardiovascular diseases, thromboembolic disorders, and chronic conditions that require ongoing blood coagulation monitoring. As conditions like deep vein thrombosis (DVT), atrial fibrillation, and pulmonary embolism become more prevalent, the demand for reliable and efficient coagulation analyzers has surged. These conditions often require patients to be placed on anticoagulant therapies, necessitating frequent monitoring to ensure therapeutic efficacy and prevent adverse effects, which in turn increases the demand for both laboratory-based and point-of-care coagulation testing. The increasing use of personalized medicine is also contributing to the market’s growth. With the rise of individualized treatment plans, particularly in oncology and cardiovascular care, the need for precise and frequent monitoring of blood coagulation has become essential. Personalized therapies, such as gene therapies or targeted biologics, often come with specific risks related to blood clotting, requiring close and continuous observation. Additionally, the growing aging population globally is another significant factor. Older adults are more susceptible to clotting disorders and are more likely to require regular coagulation testing to manage conditions such as stroke, diabetes, and heart disease. This demographic shift is driving steady demand for advanced hemostasis analyzers. Another driver of market growth is the expansion of healthcare infrastructure in emerging markets, where governments and healthcare providers are investing in modern diagnostic tools to meet growing patient demand. Finally, technological innovations, such as the integration of automation, AI, and real-time data sharing, are making coagulation analyzers more efficient, accurate, and user-friendly. These advancements are helping laboratories and healthcare providers meet the increasing demand for rapid and precise coagulation testing, driving further growth in the market. Together, these factors underscore the expanding importance of coagulation analyzers in modern healthcare, ensuring their continued relevance in the diagnosis and management of blood clotting disorders.

Select Competitors (Total 41 Featured) -

  • Alere, Inc.
  • Diagnostica Stago SAS
  • Helena Laboratories, Inc.
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Coagulation / Hemostasis Analyzers - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular and Hematological Disorders Spurs Demand for Coagulation/ Hemostasis Analyzers
    • Aging Global Population Drives Adoption of Hemostasis Analyzers for Chronic Disease Management
    • Shift Towards Personalized Medicine Expands the Market for Advanced Coagulation/Hemostasis Analyzers
    • Utilization of Point-of-Care Coagulation Testing Drives Demand for Portable Hemostasis Analyzers
    • Here's How Direct Oral Anticoagulants (DOACs) Generate the Need for Specialized Hemostasis Analyzers
    • Increased Demand for Faster and More Reliable Diagnostic Results Drives Adoption of Automated Hemostasis Analyzers
    • Improving Healthcare Infrastructure in Developing Regions Expands the Addressable Market for Hemostasis Analyzers
    • Increasing Awareness of Bleeding Disorders Drives Early Diagnostic Adoption and Growth in Hemostasis Analyzer Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Coagulation / Hemostasis Analyzers Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Clinical Laboratory Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Clinical Laboratory Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Clinical Laboratory Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Point-of-Care Testing Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Point-of-Care Testing Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Point-of-Care Testing Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Optical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Optical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Optical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Mechanical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Mechanical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Mechanical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Electrochemical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Electrochemical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Electrochemical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • INDIA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Coagulation / Hemostasis Analyzers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030
  • AFRICA
    • Coagulation / Hemostasis Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Coagulation / Hemostasis Analyzers by Product - Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Coagulation / Hemostasis Analyzers by Product - Percentage Breakdown of Value Sales for Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Coagulation / Hemostasis Analyzers by Technology - Optical, Mechanical, Electrochemical and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Coagulation / Hemostasis Analyzers by Technology - Percentage Breakdown of Value Sales for Optical, Mechanical, Electrochemical and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제